Inter Pharma Share Price

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 23/07/2026			5-day change	1st Jan Change
5.300 ^THB	+2.91%		+6.43%	+15.22%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
22/07/26	THB 5.300	+2.91%	499,551
22/07/26	THB 5.150	+0.98%	988,517
21/07/26	THB 5.100	+2.00%	277,769
20/07/26	THB 5.000	-0.99%	441,225
17/07/26	THB 5.050	+1.00%	284,367

End-of-day quote Thailand S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Cap	3.09B 91.27M 80.27M 74.57M 68.58M 129M 8.84B 131M 892M 348M 4.31B 343M 335M 14.96B	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	3.21B 94.79M 83.37M 77.45M 71.23M 134M 9.18B 136M 926M 361M 4.48B 356M 348M 15.53B	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-01	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
11-11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
11-11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI
13/11/24	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

17/08/22	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/08/22	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/08/22	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1	PU

1 day	+2.91%
1 week	+6.43%
Current month	+18.83%
1 month	+19.37%
3 months	+29.27%
6 months	+18.30%
Current year	+15.22%

1 week	4.98	5.3
1 month	4.32	5.3
Current year	3.68	5.3
1 year	3.14	5.3
3 years	2.02	7.88
5 years	2.02	14.46
10 years	1.62	15.14

Inter Pharma Share Price

Stocks

IP

TH9474010005

Pharmaceuticals

Valuation: Inter Pharma

Chart: Inter Pharma

Latest news : Inter Pharma

Press Releases: Inter Pharma

Quotes and Performance

Course Extremes

Managers and Directors: Inter Pharma

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	31/01/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	22/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Kamtorn Sila-on BRD	Director/Board Member	56	07/02/2021
Udom Kachintorn CHM	Chairman	72	16/12/2019
Napaporn Dechakarat BRD	Director/Board Member	51	13/06/2017

Date	Insider	Type	Main position	Quantity	% Market Cap.
21/05/26	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	60,000	0.0099%
21/05/26	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	60,000	0.0099%
20/05/26	Trinnawat Thanitnithiphan	Buy	Chief Executive Officer	22,600	0.0037%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	+2.91%	+6.43%	+62.58%	-29.41%	92.33M
ELI LILLY AND COMPANY	+1.97%	+1.43%	+48.44%	+158.18%	1,037B
JOHNSON & JOHNSON	+1.42%	+3.72%	+53.32%	+51.55%	615B
ABBVIE INC.	+1.43%	+0.99%	+34.83%	+79.44%	448B
ROCHE HOLDING AG	+5.14%	+5.84%	+37.54%	+27.28%	326B
NOVARTIS AG	+1.85%	+4.64%	+38.53%	+39.87%	293B
ASTRAZENECA PLC	-0.11%	+0.97%	+22.57%	+17.81%	264B
NOVO NORDISK A/S	+0.25%	-3.10%	-24.44%	-42.25%	216B
AMGEN INC.	+1.49%	-0.02%	+20.14%	+57.80%	198B
GILEAD SCIENCES, INC.	+0.40%	-3.99%	+15.23%	+68.50%	162B
Average	+1.70%	+1.50%	+30.88%	+42.88%	355.75B
Weighted average by Cap.	+1.61%	+1.47%	+36.34%	+75.89%

	2024	2025
Net sales	1.91B 56.52M 49.71M 46.18M 42.47M 79.65M 5.47B 81.08M 552M 215M 2.67B 212M 208M 9.26B	2.21B 65.45M 57.57M 53.48M 49.18M 92.24M 6.34B 93.89M 639M 249M 3.09B 246M 240M 10.73B
Net income	37.28M 1.1M 969K 900K 828K 1.55M 107M 1.58M 10.77M 4.2M 52.05M 4.14M 4.05M 181M	122M 3.62M 3.18M 2.96M 2.72M 5.1M 350M 5.19M 35.35M 13.79M 171M 13.58M 13.29M 593M
Net Debt	209M 6.18M 5.43M 5.05M 4.64M 8.7M 598M 8.86M 60.34M 23.54M 292M 23.19M 22.68M 1.01B	119M 3.53M 3.1M 2.88M 2.65M 4.97M 342M 5.06M 34.46M 13.44M 167M 13.24M 12.95M 578M